2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of …

Authors/Task Force Members, SG Priori… - Ep …, 2015 - academic.oup.com
The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the …

P Lancellotti, PA Pellikka, W Budts… - European Heart …, 2016 - academic.oup.com
A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Development and validation of a risk score to predict QT interval prolongation in hospitalized patients

JE Tisdale, HA Jaynes, JR Kingery… - … Quality and Outcomes, 2013 - Am Heart Assoc
Background—Identifying hospitalized patients at risk for QT interval prolongation could lead
to interventions to reduce the risk of torsades de pointes. Our objective was to develop and …

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine

D De Berardis, G Rapini, L Olivieri… - … advances in drug …, 2018 - journals.sagepub.com
Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical
antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it …

[HTML][HTML] QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes

K Wenzel-Seifert, M Wittmann… - Deutsches Ärzteblatt …, 2011 - ncbi.nlm.nih.gov
Method We searched PubMed for pertinent literature on the risk of QTc prolongation and/or
TdP associated with commonly used psychotropic drugs. Results Thioridazine and …

Anxiety in patients with schizophrenia: Epidemiology and management

H Temmingh, DJ Stein - CNS drugs, 2015 - Springer
Anxiety symptoms can occur in up to 65% of patients with schizophrenia, and may reach the
threshold for diagnosis of various comorbid anxiety disorders, including obsessive …

Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents

CU Correll, JB Penzner, UH Parikh… - Child and …, 2006 - childpsych.theclinics.com
Despite the limited availability of randomized, controlled evidence regarding the efficacy and
safety of second-generation antipsychotics (SGAs) in pediatric populations [1, 2], this class …

QT alterations in psychopharmacology: proven candidates and suspects

PA Alvarez, J Pahissa - Current drug safety, 2010 - ingentaconnect.com
Psychotropics are among the most common causes of drug induced acquired long QT
syndrome. Blockage of Human ether-ago-go-related gene (HERG) potassium channel by …

Assessing QT interval prolongation and its associated risks with antipsychotics

J Nielsen, C Graff, JK Kanters, E Toft, D Taylor… - CNS drugs, 2011 - Springer
Several antipsychotics are associated with the ventricular tachycardia torsade de pointes
(TdP), which may lead to sudden cardiac death (SCD), because of their inhibition of the …

Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect-comprehensive overview of clinical trials

B Wiśniowska, Z Tylutki, G Wyszogrodzka… - BMC Pharmacology and …, 2016 - Springer
Background Proarrhythmia assessment is one of the major concerns for regulatory bodies
and pharmaceutical industry. ICH guidelines recommending preclinical tests have been …